During summer, the opposite problem applies
The complete guide to semaglutide with B12 explains the differences in detail
Genetic predispositions in GLP-1 and GIPR pathways, along with biomarkers, can inform whether the current agent is optimal or whether a different single agent might be more effective for that individual's physiology
Scheen has received lecturer/scientific advisor/clinical investigator fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, and NovoNordisk, and has worked as a clinical investigator in the EMPA-REG OUTCOME, CANVAS-R, DECLARE-TIMI 58, LEADER and HARMONY Outcomes cardiovascular outcome trials
Key Takeaways Semaglutides like Ozempic and Wegovy, as well as tirzepatides like Mounjaro and Zepbound, have become popular medications for managing both weight and diabetes